22nd Century Group has appointed Michael Koganov to its board of directors. Koganov will serve as chair of the company’s scientific and technical advisory committee and as a member of its finance committee.
Koganov is recognized as a leading expert in the development of natural products using plant biotechnology and has achieved considerable accomplishments in physico-chemistry, biochemistry, bioelectrochemistry and biotechnology.
Among other things, he is credited with developing electro-membrane technology for the comprehensive processing of plants to produce protein concentrates and secondary metabolites. Koganov co-founded IBT, which developed the proprietary and sustainable Zeta Fraction technology.
“We are excited to welcome Michael to our board,” said 22nd Century’s board chair, Nora Sullivan in a statement. “As a recognized expert in plant biotechnology and life science, Michael will further strengthen our leadership team with his highly relevant expertise related to the Company’s strategic, scientific initiatives.”